Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Eukaryotic cells employ a plethora of processes to repair different types of DNA lesions, which together are crucial to the maintenance of genomic integrity. Failure to repair DNA damage underlies cancer development and genetic disorders such as Fanconi anaemia, and repair pathways are also involved in other physiological processes such as immunity and ageing. Research into DNA damage repair has gradually shifted from studying the functions of specific repair pathways to understanding how they are integrated into the DNA damage response. It is now becoming clear that different repair pathways can crosstalk, owing to the capacity of certain proteins to function in the signalling and repair of different DNA lesions. Furthermore, it has been demonstrated that DNA repair factors and pathways are intricately connected with cellular processes such as DNA replication, transcription and protein post-translational modifications.
In this specially commissioned Focus issue, we highlight the crosstalk between different DNA damage repair pathways, their relationships with other cellular processes and the implications for physiology and disease. Alan D'Andrea and colleagues discuss the repair of DNA interstrand crosslinks by the Fanconi anaemia pathway, which involves components of different repair processes, and which also functions in DNA replication and cell cycle regulation. Thomas Kunkel and colleagues describe ribonucleotide incorporation into DNA during replication and the ensuing DNA damage and its repair by different mechanisms. Niels Mailand and colleagues delve into the complex crosstalk between signalling by ubiquitin, SUMO and other ubiquitin-like modifiers in the repair of DNA double-strand breaks (DSBs). Last but not least, Eros Lazzerini-Denchi and Agnel Sfeir describe how the DNA damage response is kept in check at telomeres to avoid chromosomal rearrangements and tumorigenesis, and how telomere research has helped to uncover key steps in DSB repair. The Focus issue also features a Comment by Tomas Lindahl on the experimental properties and advantages of keeping DNA in the organic solvent glycol.
Recent insights into the roles of poly(ADP-ribose) polymerase 1 (PARP1) in mediating various DNA repair pathways, stabilizing DNA replication and modulating chromatin structure are being exploited clinically for the treatment of DNA repair-deficient cancers.
Proteins of the Fanconi anaemia pathway are master regulators of genomic integrity through their interactions with other DNA repair pathways to repair interstrand crosslinks, stabilize replication forks and regulate cytokinesis.
Ribonucleotides are incorporated into DNA by various mechanisms, including by DNA polymerases during replication. Such ribonucleotides may have physiological functions, but their presence is typically associated with diverse structural aberrations and interferes with fundamental processes, including DNA replication, repair and transcription. Thus, efficient mechanisms of ribonucleotide removal are key to maintaining genomic integrity and functionality.
Double-strand break (DSB) repair at telomeres — the ends of linear chromosomes — can cause chromosome end fusions and genomic instability, which drives tumorigenesis. As several mechanisms protect mammalian telomeres from the DNA damage response, telomeres have emerged as a system to uncover key steps in DSB repair.
Signalling by ubiquitin, SUMO and other ubiquitin-like modifiers (UBLs), and crosstalk between these modifications, underlies cellular responses to DNA double-strand breaks (DSBs). Important insights have been gained into the mechanisms by which ubiquitin and UBLs regulate protein interactions at DSB sites to enable accurate repair in mammalian cells, thereby protecting genome integrity.
Tomas Lindahl presents a case for keeping DNA in the organic solvent glycol, in which it keeps its activity and is better protected from contamination and, potentially, radiation.
As far as James Haber is concerned, the big picture is all he wants of protein structures. This was not the case, however, with the structure of RecA, published in 2008.
The long non-coding RNA LINP1 facilitates double-strand break repair in triple-negative breast cancer through non-homologous end joining, by recruiting DNA-PKcs to sites of damage.